Childhood Disintegrative Disorder (CDD), historically known as Heller’s syndrome or disintegrative psychosis, is a rare condition characterized by the dramatic loss of developmental skills after a period of apparently typical development. It was once classified among the pervasive developmental disorders. Since the publication of the DSM-5 in 2013, CDD is no longer a separate diagnosis and is included within Autism Spectrum Disorder (ASD). Nevertheless, clinicians continue to recognize its distinctive pattern of late and often profound regression.
The most striking feature is the child’s period of normal or near-normal development. Unlike many children with autism, who may show differences during infancy or toddlerhood, children historically diagnosed with CDD generally developed appropriately for at least their first two years. Regression typically occurred between ages 2 and 10, although the timing varied. The decline could unfold over several months or appear relatively rapidly.
Before regression becomes obvious, some children experience a prodromal period. They may become unusually anxious, irritable, hyperactive, fearful, or socially withdrawn. Parents sometimes report that children seemed distressed or confused as their abilities changed. Research on developmental regression emphasizes that the phenomenon can affect multiple areas of functioning rather than language alone.
The regression may involve expressive or receptive language, with a child losing sentences, words, or eventually speech. Social abilities can deteriorate, including reduced interaction and loss of previously acquired self-care skills. Previously established toilet training may disappear, while imaginative or cooperative play can diminish. Motor abilities may also decline, producing clumsiness, poor coordination, or balance problems. Repetitive behaviors and restricted interests characteristic of autism may emerge or become more prominent.
Because developmental regression can have many causes, diagnosis requires careful medical and developmental evaluation. Autism is one possibility, but clinicians must also consider epileptic disorders, genetic syndromes, metabolic diseases, and other neurological conditions. Landau-Kleffner syndrome, for example, can cause major language regression associated with abnormal electrical brain activity. Recent research also supports considering genetic or genomic testing in children with unexplained developmental regression, particularly when neurological signs are present.
Seizures and abnormal electroencephalograms (EEGs) have been reported more often in historical CDD populations than in typical autism populations, although epilepsy is not present in every child. An EEG is therefore particularly relevant when regression is accompanied by seizures, unusual neurological symptoms, or atypical loss of language. Rarely, regression may be associated with specific medical disorders, including certain metabolic or neurodegenerative diseases.
The long-term outlook is often challenging because substantial losses in language, cognition, adaptive behavior, and social functioning may persist. Treatment focuses on the child’s individual needs rather than CDD itself. Speech and language therapy, educational support, behavioral interventions, occupational therapy, and family support can help maximize functioning. Medications may sometimes be used for seizures or severe associated behavioral symptoms.
Although CDD is no longer a standalone DSM-5 diagnosis, its distinctive pattern remains clinically important. Any sudden or progressive loss of previously acquired skills warrants prompt professional assessment, because identifying an underlying neurological, genetic, or metabolic cause can influence treatment and family planning.
Childhood Disintegrative Disorder: Understanding a Rare Form of Developmental Regression
